Comparison Between Subacromial Ultrasound Guided and Systemic Steroid Injection for Frozen Shoulder

Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04931511
Collaborator
(none)
180
1
2
15
12

Study Details

Study Description

Brief Summary

This study aim to compare the efficacy of guteal muscle injection and subacromial ultrasound guided injection to treat frozen shoulder. Firstly, in order to calculate the sample size correctly, we start the preliminary study. Besides, in order to propose clinical new technology which combines the advantages of the two therapies, improve the efficacy ratio of frozen shoulder therapy, and provide a frozen shoulder treatment plan according to health economics.

Condition or Disease Intervention/Treatment Phase
  • Drug: Compound betamethasone Injection(Gluteal muscle injection)
  • Drug: Compound betamethasone Injection(Subacromial Ultrasound Guided injection)
  • Behavioral: Physical therapy
Phase 4

Detailed Description

In recent years, there have been studies suggesting that small doses of corticosteroid systemic medication and joint local injection to treat shoulder sleeve disease is equivalent, frozen shoulder is clinically in addition to shoulder sleeve disease another common cause of shoulder pain disease, local injection of small dose of corticosteroid is a clinically commonly used treatment of frozen shoulder mature therapy, however, because of the risk of joint infection and other serious complications, and it's personnel experience depended and high qualification requirements, resulting in higher treatment costs. However, it has not been widely used in clinical applications and is generally used as a second-line therapy for the treatment of frozen shoulders. There are studies suggesting that joint cavity hormone injection may be mainly effective through its systemic effect, however, there is currently no random blind control study comparing small doses of hormone systemic injection with local injection of shoulder joints to freeze shoulder, if the equivalence of the two can be confirmed through such studies will greatly change the clinical treatment of frozen shoulders, with hip injection and other systemic medication will provide great health economic advantages, and can avoid the inherent risk of joint cavity injection, reduce the social cost of frozen shoulder treatment.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
180 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Comparison Between Subacromial Ultrasound Guided and Systemic Steroid Injection for Frozen Shoulder: a Randomized Double Blind Study
Actual Study Start Date :
Jun 1, 2021
Anticipated Primary Completion Date :
Sep 1, 2022
Anticipated Study Completion Date :
Sep 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Gluteal muscle injection plus physical therapy group

Gluteal muscle injection (corticosteroid 1ml+normal saline 4ml) + Subacromial Ultrasound Guided injection (sodium chloride 5ml) + Physical therapy

Drug: Compound betamethasone Injection(Gluteal muscle injection)
Gluteal muscle injection(Compound betamethasone 1ml + Sodium Chloride Injection 4ml) + Subacromial Ultrasound Guided injection(Sodium Chloride Injection 5ml)
Other Names:
  • corticosteroid
  • Behavioral: Physical therapy
    paticipant will be teached by the Physicaltherapist to reduce the shoulder pain at home

    Experimental: Subacromial Ultrasound Guided injection plus physical therapy group

    Gluteal muscle injection(sodium chloride 5ml)) + Subacromial Ultrasound Guided injection(corticosteroid 1ml+normal saline 4ml) + Physical therapy

    Drug: Compound betamethasone Injection(Subacromial Ultrasound Guided injection)
    Gluteal muscle injection (Sodium Chloride Injection 5ml)+ Subacromial Ultrasound Guided injection (corticosteroid 1ml+Sodium Chloride Injection 4ml)
    Other Names:
  • corticosteroid
  • Behavioral: Physical therapy
    paticipant will be teached by the Physicaltherapist to reduce the shoulder pain at home

    Outcome Measures

    Primary Outcome Measures

    1. The Change of Shoulder Pain and Disability Index (SPADI) [0,1,2,4,8,12 weeks]

      The SPADI contains 13 items that assess two domains; a 5-item subscale that measures pain and an 8-item subscale that measures disability.

    Secondary Outcome Measures

    1. The Change of Numeric Rating Scale for Pain (NRS) (Score: 0-10) [0,1,2,4,8,12 weeks]

      The NRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of their pain. The common format is a horizontal bar or line. Similar to the pain VAS, the NRS is anchored by terms describing pain severity extremes

    2. Anterior flexion of shoulder joint (0-180°) [0,1,2,4,8,12 weeks]

      Passive activity of the shoulder joint

    3. shoulder joint abduction (0-180°) [0,1,2,4,8,12 weeks]

      Passive activity of the shoulder joint

    4. shoulder internal rotator (1-18 score) [0,1,2,4,8,12 weeks]

      The thumb tip reaches the highest point of the back cone:Score1-12: T1-T12; Score13-17:L1-L5;18: below the sacrum;

    5. shoulder external rotator (0-180°) [0,1,2,4,8,12 weeks]

      Passive activity of the shoulder joint

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 75 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
      1. Primary frozen shoulder
      1. Older than 18 years of age and less than 75 years of age
      1. The SHOULDER PAIN VAS SCORE IS GREATER THAN 3 POINTS AND LASTS AT LEAST 1 MONTH AND LESS THAN 9 MONTHS
      1. The passive activity of the side shoulder joint in at least 2 directions in the three directions of front, internal and outer rotation decreased by more than 30 degrees compared to the side shoulder joint or the normal reference value
      1. corticosteroid injections were not given within 3 months of visit
    Exclusion Criteria:
      1. A history of trauma, osteoarthritis, tumors, etc.
      1. Combined shoulder sleeve injury with magnetic resonance or B-mode ultrasound confirmed
      1. There is a history of corticosteroid injections within 3 months of visit
      1. Suffer from a partial infection of the side shoulder or other cases where there is a contraindication of shoulder injection
      1. Both side shoulder joints become ill at the same time
      1. The patient has not signed an informed consent form

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Second Affiliated Hospital of Zhejiang University School of Medicine Hanzhou Zhejiang China 310000

    Sponsors and Collaborators

    • Second Affiliated Hospital, School of Medicine, Zhejiang University

    Investigators

    • Principal Investigator: Pintong Huang, Department of Ultrasound in Medicine, The Second Affiliated AHospital of Zhejiang University

    Study Documents (Full-Text)

    More Information

    Publications

    None provided.
    Responsible Party:
    huang pintong, Director of the department of ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University
    ClinicalTrials.gov Identifier:
    NCT04931511
    Other Study ID Numbers:
    • Study 2020-1064
    First Posted:
    Jun 18, 2021
    Last Update Posted:
    Dec 8, 2021
    Last Verified:
    Nov 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Dec 8, 2021